Integrated Filing — IndAS



General information about company

Scrip Code 500201
NSE Symbol INDIAGLYCO
MSEI Symbol NOTLISTED
ISIN INE560A01023
Name of company INDIA GLYCOLS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 10-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 03-02-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 10-02-2026   16:00:00
End date and time of board meeting 10-02-2026   17:12:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 2,55,110.00 7,46,662.00
Other income 74.00 431.00
Total income 2,55,184.00 7,47,093.00
2 Expenses
(a) Cost of materials consumed 59,782.00 1,92,777.00
(b) Purchases of stock-in-trade 4,084.00 14,843.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 5,306.00 (2,116.00)
(d) Employee benefit expense 3,523.00 9,840.00
(e) Finance costs 4,681.00 14,077.00
(f) Depreciation, depletion and amortisation expense 4,122.00 11,415.00
(f) Other Expenses
1 Excise Duty 1,44,870.00 4,23,156.00
2 Power and Fuel 10,579.00 31,281.00
3 Other Expenses 9,419.00 28,606.00
Total other expenses 1,64,868.00 4,83,043.00
Total expenses 2,46,366.00 7,23,879.00
3 Total profit before exceptional items and tax 8,818.00 23,214.00
4 Exceptional items (83.00) (83.00)
5 Total profit before tax 8,735.00 23,131.00
6 Tax expense
7 Current tax 1,291.00 3,020.00
8 Deferred tax 1,013.00 2,867.00
9 Total tax expenses 2,304.00 5,887.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 6,431.00 17,244.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 326.00 3,344.00
16 Total profit (loss) for period 6,757.00 20,588.00
17 Other comprehensive income net of taxes (25.00) (82.00)
18 Total Comprehensive Income for the period 6,732.00 20,506.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 6,732.00 20,506.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 3,351.00 3,351.00
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 10.79 32.87
Diluted earnings (loss) per share from continuing operations 10.79 32.87
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 10.79 32.87
Diluted earnings (loss) per share from continuing and discontinued operations 10.79 32.87
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Note on Financial Results: At point no.21: 'The Board of Directors of the Company at their meeting held on 16th October, 2025 had considered and approved the raising funds through issuance of up to of 51,03,765 Equity Shares, of face value of Rs. 5/- (Rupees Five) each, at a price of Rs. 915/- per Equity Share, (including a premium of Rs. 910/- per equity share), determined inaccordance with provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, for cash, for an aggregate amount of up to Rs. 4,66,99,44,975/- on preferential basis and the same has been approved by the Shareholders of the Company at their Extra Ordinary General Meeting held on 12th November, 2025. The Preferential Allotment Committee of the Board completed the allotment of the aforesaid equity shares to the respective allottee on 24th November, 2025 and the Company's paid up share capital was accordingly increased to Rs. 33,51,33,825/-. The Listing and Trading approvals from the Stock exchanges for above acquired equity shares were obtained on 5th Jnauary, 2026 effective from 6th January, 2026.' 'Face value of equity share capital' of Rs.5 is the Face value per equity share.'



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Bio-based Specialities and Performance Chemicals 31,302.00 90,134.00
2 Potable Spirits 1,79,346.00 5,25,634.00
3 Ennature Biopharma 5,034.00 14,428.00
4 Bio-Fuel 39,428.00 1,16,466.00
Total Segment Revenue 2,55,110.00 7,46,662.00
Less: Inter segment revenue 0.00 0.00
Revenue from operations 2,55,110.00 7,46,662.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Bio-based Specialities and Performance Chemicals 4,018.00 10,419.00
2 Potable Spirits 7,243.00 21,715.00
3 Ennature Biopharma 204.00 422.00
4 Bio-Fuel 3,299.00 8,502.00
Total Profit before tax 14,764.00 41,058.00
i. Finance cost 4,681.00 14,077.00
ii. Other Unallocable Expenditure net off Unallocable income 1,022.00 506.00
Profit before tax 9,061.00 26,475.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Bio-based Specialities and Performance Chemicals 3,37,356.00 3,37,356.00
2 Potable Spirits 61,474.00 61,474.00
3 Ennature Biopharma 43,121.00 43,121.00
4 Bio-Fuel 1,34,788.00 1,34,788.00
Total Segment Asset 5,76,739.00 5,76,739.00
Un-allocable Assets 48,013.00 48,013.00
Net Segment Asset 6,24,752.00 6,24,752.00
4 Segment Liabilities
Segment Liabilities
1 Bio-based Specialities and Performance Chemicals 72,012.00 72,012.00
2 Potable Spirits 30,255.00 30,255.00
3 Ennature Biopharma 7,299.00 7,299.00
4 Bio-Fuel 7,440.00 7,440.00
Total Segment Liabilities 1,17,006.00 1,17,006.00
Un-allocable Liabilities 2,18,049.00 2,18,049.00
Net Segment Liabilities 3,35,055.00 3,35,055.00
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) Note1: Since there is no option to fill 'Exceptional Items' & 'Share of Profit and loss of JV' in the utility, the same is clubbed with 'Unallocated corporate expenses net of unallocable income'.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit and loss (32.00) (112.00)
Total Amount of items that will not be reclassified to profit and loss (32.00) (112.00)
2 Income tax relating to items that will not be reclassified to profit or loss (8.00) (28.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 1.00 (2.00)
5 Total Other comprehensive income (25.00) (82.00)